Russell Investments Group, Ltd. Axsome Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,015 shares of AXSM stock, worth $98,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,015

Previous 1,834 44.66%

Holding current value

$98,830

Previous $147,000 38.1%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.93 - $95.84 $64,643 - $78,492	-819 Reduced 44.66%	1,015 $91,000
Q2 2024 Aug 08, 2024	BUY	$65.72 - $80.5 $68,545 - $83,961	1,043 Added 131.86%	1,834 $147,000
Q1 2024 May 08, 2024	BUY	$69.39 - $97.64 $53,916 - $75,866	777 Added 5550.0%	791 $63,000
Q4 2023 Feb 05, 2024	SELL	$57.42 - $83.61 $513,909 - $748,309	-8,950 Reduced 99.84%	14 $1,000
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $1.08 Million - $1.29 Million	-15,635 Reduced 63.56%	8,964 $626,000
Q2 2023 Aug 10, 2023	BUY	$58.41 - $90.35 $1.44 Million - $2.22 Million	24,578 Added 117038.1%	24,599 $1.77 Million
Q1 2023 May 09, 2023	BUY	$58.39 - $75.0 $1,226 - $1,575	21 New	21 $1,000
Q4 2021 Jan 21, 2022	SELL	$30.7 - $43.36 $383,934 - $542,260	-12,506 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$19.91 - $68.26 $48,082 - $164,847	-2,415 Reduced 16.19%	12,506 $411,000
Q2 2021 Aug 04, 2021	BUY	$50.63 - $73.5 $407,318 - $591,307	8,045 Added 117.0%	14,921 $1.01 Million
Q1 2021 May 10, 2021	BUY	$55.91 - $81.44 $40,590 - $59,125	726 Added 11.8%	6,876 $388,000
Q4 2020 Feb 08, 2021	SELL	$66.31 - $86.52 $135,869 - $177,279	-2,049 Reduced 24.99%	6,150 $500,000
Q3 2020 Nov 09, 2020	SELL	$68.34 - $85.84 $1.03 Million - $1.29 Million	-15,005 Reduced 64.67%	8,199 $583,000
Q2 2020 Aug 05, 2020	BUY	$49.87 - $98.69 $1.07 Million - $2.11 Million	21,415 Added 1197.04%	23,204 $1.9 Million
Q1 2020 May 06, 2020	BUY	$41.2 - $101.31 $73,706 - $181,243	1,789 New	1,789 $105,000

Others Institutions Holding AXSM

# of Institutions

324

Shares Held

37.7M

Call Options Held

797K

Put Options Held

747K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.18B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Axsome Therapeutics, Inc. Transaction History